EB-203

· EyebioKorea, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EB-203, covering 2024-08-27 to 2024-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration [Phase 2]

See pricing